• Tomivosertib Workflows for MNK1 Inhibitor Research

  2026-08-25

  Build reproducible Tomivosertib assays around direct target engagement, eIF4E phosphorylation, viability, and progenitor function. The workflow emphasizes acute myeloid leukemia applications while showing how the same MNK-eIF4E logic can be adapted cautiously to glioblastoma, metabolic, and neuronal models.

• Genotyping as a Translational Control Point

  2026-08-25

  Rapid genotyping is more than a convenience: it is a quality-control layer connecting model identity, allele status, and mechanistic interpretation. This thought-leadership article examines how streamlined genomic DNA preparation can support studies inspired by Lactobacillus gasseri, NR1I3, and E-cadherin biology while offering strategic guidance for cross-species translational workflows.

• Canagliflozin: SGLT2 Inhibitor and Kidney Mitochondria

  2026-08-24

  Canagliflozin is a selective SGLT2 inhibitor that reduces renal glucose reabsorption and increases urinary glucose excretion. Recent mouse evidence links treatment with improved proximal-tubule mitochondrial structure and bioenergetics, while sex-specific responses and model limitations remain important.

• HNF4A-AS1 and Sorafenib Resistance in HCC

  2026-08-24

  A 2024 Theranostics study identifies the liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib-induced ferroptosis in hepatocellular carcinoma. Its proposed METTL3–m6A–DECR1 pathway connects RNA regulation with PUFA remodeling, offering a mechanistic framework for studying therapeutic resistance while highlighting complementary metabolic readouts.

• SGC-CBP30: Causal Probes for LUAD Enhancers

  2026-08-23

  SGC-CBP30 is a CREBBP/EP300 bromodomain inhibitor for testing how enhancer-linked transcriptional coactivator activity shapes lung adenocarcinoma biology. This article presents an assay framework that separates bromodomain dependence from broader TGF-β/SMAD3 and super-enhancer effects.

• GluN2A/B, Connexins, and TMJ Inflammatory Allodynia

  2026-08-22

  The reference study identifies a subunit-specific pathway linking GluN2A and GluN2B N-methyl-D-aspartate receptors with connexin- and pannexin-dependent communication in the trigeminal ganglion during temporomandibular joint inflammation. By combining conditional knockout mice, behavioral testing, satellite glial cell experiments, and pathway analysis, it clarifies how peripheral sensitization may sustain orofacial inflammatory allodynia.

• SPRTN’s Dual Ubiquitin Binding in DPC Repair

  2026-08-22

  The reference preprint identifies a ubiquitin-binding region within the N-terminal catalytic region of SPRTN and shows how ubiquitin chains enhance selective DNA-protein crosslink proteolysis. Its central contribution is a mechanistic model in which ubiquitination acts as a rapid substrate-recognition signal, helping explain how SPRTN distinguishes damaged chromatin proteins from unmodified substrates.

• Caffeine Workflows for Cancer and Metabolism

  2026-08-21

  Build reproducible Caffeine experiments for sarcoma cell inhibition, VPA combination testing, and energy-balance studies in diet-induced obesity mouse models. This guide also explains how the ALDH2 ischemia literature can inform assay controls without overstating Caffeine’s cardiovascular evidence.

• FXR–KLF11 Signaling in Contrast-Induced AKI

  2026-08-20

  A 2026 study identifies an FXR–KLF11 transcriptional axis that protects against contrast-induced acute kidney injury by suppressing JAK2/STAT3 signaling. Using mouse, HK-2 cell, transcriptomic, reporter, chromatin, and genetic approaches, the work connects CDCA-driven FXR activation with reduced tubular inflammation, apoptosis, and tissue injury.

• Artesunate: In Vitro Cancer Assay Workflows

  2026-08-20

  Artesunate is an artemisinin derivative for dissecting growth inhibition, ferroptosis, and pathway-linked responses in cancer cell models. This workflow guide translates those properties into reproducible small cell lung carcinoma research and esophageal squamous cell carcinoma assay strategies.

• Electrical Stimulation Enhances Nanoparticle Endocytosis

  2026-08-19

  The reference study shows that alternating-current electrical stimulation increases magnetic nanoparticle uptake by cancer cells without requiring particle-surface functionalization. In osteosarcoma cells, the effect was associated with macropinocytosis, reduced F-actin content, and elevated intracellular Ca2+, with corresponding improvements in magnetic hyperthermia and MRI performance.

• Biotin in Kinesin Transport Assay Design

  2026-08-19

  Biotin and Vitamin B7 are more than metabolic cofactors: they can provide a precise capture and detection interface for reconstituted motor-protein assays. This article connects biotin chemistry with the BicD–MAP7 model of kinesin-1 activation to guide better experimental design.

• Midecamycin: Mechanism, MICs, and Research Use

  2026-08-18

  Midecamycin is a 16-membered, acetoxy-substituted macrolide antibiotic and bacterial protein synthesis inhibitor with strongest reported activity against Gram-positive organisms. Its A2058-directed mechanism, glycosylation-sensitive 2''-OH site, MIC benchmarks, solubility limits, and storage requirements define its use as an antibiotic research compound.

• NET-DNA–CCDC25 Axis in Intestinal Repair

  2026-08-18

  This FASEB Journal study identifies a mechanistic link between neutrophil extracellular trap DNA, CCDC25 signaling in group 3 innate lymphoid cells, and impaired IL-22-dependent intestinal epithelial repair. Its combination of mouse models, transcriptomics, cell perturbation, and epithelial barrier assays suggests that NET-DNA is not only a marker of ulcerative colitis activity but also an active suppressor of mucosal healing.

• S-Adenosylhomocysteine in Neural Differentiation Assays

  2026-08-17

  S-Adenosylhomocysteine enables controlled testing of how methylation potential may intersect with radiation-induced neural differentiation. This workflow combines SAH dosing, SAM/SAH ratio modulation, pathway-resolved readouts, and rescue controls without overstating findings that have not yet been demonstrated in neural cells.

8484 records 1/566 page Next 12345 下5页 Last page